12 results
Dyspnea - Differential Diagnosis Framework

Cardiovascular Causes of Dyspnea:
 • Myocardium:
	- Heart failure
	- CAD/ACS
	- Valvulopathy
 • Electrical:
	-
- Tamponade Pulmonary ... Causes of Dyspnea ... • Parenchyma: ILD ... Transverse myelitis • Hematology ... #pulmonary
Causes of Chronic Dyspnea - Differential Diagnosis Algorithm
Pericardial
 • Effusion
 • Cardiac Tamponade*
 • Constriction
Myocardial
 •
Dyspnea - Differential ... Diagnosis Algorithm ... Interstitium • ILD ... Acidosis #Chronic #Dyspnea ... Differential #Diagnosis #Algorithm
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... and relief of dyspnea ... the patient’s dyspnea ... Effusions #MPE #Algorithm ... #Management #ATS
COPD Management Algorithm - GOLD 2019 guidelines 

Categorize into COPD GOLD A-D -> Initiate first-line therapy
COPD Management ... Algorithm - GOLD ... 2019 guidelines ... #Management #Pulmonary ... #Algorithm #pharmacology
Causes of Interstitial Lung Disease - Differential Diagnosis Algorithm
Idiopathic Interstitial Pneumonia
 • (UIP) Usual Interstitial Pneumonia
Differential Diagnosis Algorithm ... slowly progressive dyspnea ... leaking out of pulmonary ... Lung #Diseases #ILD ... #Diagnosis #Algorithm
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
volume in 1 s; IL ... #GINA #Asthma #Management ... #Stepwise #Pulmonary ... StepUp #Treatment #Algorithm ... #Guidelines
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
Unknown • 6-7 cases ... History: cough, dyspnea ... Pneumonia #COP #BOOP #pulmonary ... #ILD #diagnosis ... #management
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
exclude other causes ... cardiomyopathy • Pulmonary ... typical HF sx: dyspnea ... Avoid ARBs • ICD ... e.g., <50%), ESC guidelines
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... and relief of dyspnea ... the patient’s dyspnea ... #Algorithm #Effusion ... #Pleural #Pulmonary
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
Dyspnea 3. ... Exclude other causes ... pneumonia - Pulmonary ... Exclusion of other ILDs ... #diagnosis #management